Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMP-2: Home-based Interventions to Prevent CA-MRSA Infection Recurrence
NCT02566928Phase 4Unknown
- Sponsor
- Clinical Directors Network
- Start
- Oct 2015
- Primary completion
- Nov 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mupirocin in Staphylococcus aureus infection, Staphylococcal skin infection, sponsored by Clinical Directors Network. Status: unknown.
02
Drugs
mupirocin
03
Conditions
Staphylococcus aureus infectionStaphylococcal skin infection
Beyond the preview
Go deeper on NCT02566928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566928.